Nextage Therapeutics (XTAE:NXTG) Price-to-Operating-Cash-Flow : (As of Jun. 19, 2024)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-19), Nextage Therapeutics's share price is ₪0.69. Nextage Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-0.08. Hence, Nextage Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Nextage Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

XTAE:NXTG's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.06
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Nextage Therapeutics's Cash Flow from Operations per share for the six months ended in Dec. 2023 was ₪-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-0.08.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 47.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 54.70% per year.

During the past 8 years, Nextage Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 64.50% per year. The lowest was 43.70% per year. And the median was 56.40% per year.

Nextage Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Nextage Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Price-to-Operating-Cash-Flow Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Nextage Therapeutics's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Nextage Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nextage Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nextage Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nextage Therapeutics's Price-to-Operating-Cash-Flow falls into.

Nextage Therapeutics Price-to-Operating-Cash-Flow Calculation

Nextage Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.69	/	-0.078
	=

Nextage Therapeutics's Share Price of today is ₪0.69.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nextage Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-0.08.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Nextage Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021